Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research SUNNYVALE, Calif. and OXFORD, England, April 15, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, and Oxford...